Nova [NVMI] vs Onto Innovation [ONTO] Detailed Stock Comparison
Nova
NASDAQ
Loading...
Onto Innovation
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Nova wins in 11 metrics, Onto Innovation wins in 8 metrics, with 0 ties. Nova appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Nova | Onto Innovation | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 41.14 | 21.99 | Onto Innovation |
| Price-to-Book Ratio | 8.13 | 2.47 | Onto Innovation |
| Debt-to-Equity Ratio | 24.00 | 0.76 | Onto Innovation |
| PEG Ratio | 36.17 | 14.49 | Onto Innovation |
| EV/EBITDA | 32.97 | 14.55 | Onto Innovation |
| Profit Margin (TTM) | 28.46% | 21.36% | Nova |
| Operating Margin (TTM) | 30.27% | 25.04% | Nova |
| EBITDA Margin (TTM) | 30.27% | 25.04% | Nova |
| Return on Equity | 23.87% | 11.83% | Nova |
| Return on Assets (TTM) | 10.12% | 6.46% | Nova |
| Free Cash Flow (TTM) | $218.05M | $213.77M | Nova |
| 1-Year Return | 14.31% | -53.35% | Nova |
| Price-to-Sales Ratio (TTM) | 10.78 | 4.64 | Onto Innovation |
| Enterprise Value | $7.68B | $3.91B | Nova |
| EV/Revenue Ratio | 10.32 | 3.82 | Onto Innovation |
| Gross Profit Margin (TTM) | 57.32% | 53.72% | Nova |
| Revenue per Share (TTM) | $26 | $21 | Nova |
| Earnings per Share (Diluted) | $6.63 | $4.42 | Nova |
| Beta (Stock Volatility) | 1.67 | 1.44 | Onto Innovation |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Nova vs Onto Innovation Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Nova | 2.94% | -0.01% | -8.31% | 30.81% | 4.46% | 29.45% |
| Onto Innovation | 11.08% | -2.18% | -6.10% | -25.97% | -50.43% | -45.93% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Nova | 14.31% | 134.28% | 368.90% | 2,021.07% | 4,585.64% | 9,136.92% |
| Onto Innovation | -53.35% | 9.50% | 157.29% | 173.31% | 173.31% | 173.31% |
Performance & Financial Health Analysis: Nova vs Onto Innovation
| Metric | NVMI | ONTO |
|---|---|---|
| Market Information | ||
| Market Cap | $8.02B | $4.76B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 279,150 | 1,217,430 |
| 90 Day Avg. Volume | 286,683 | 1,133,060 |
| Last Close | $270.30 | $102.95 |
| 52 Week Range | $154.00 - $291.99 | $85.88 - $228.42 |
| % from 52W High | -7.43% | -54.93% |
| All-Time High | $291.99 (Jul 07, 2025) | $238.93 (Jul 15, 2024) |
| % from All-Time High | -7.43% | -56.91% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.51% | 0.17% |
| Quarterly Earnings Growth | 0.76% | 0.37% |
| Financial Health | ||
| Profit Margin (TTM) | 0.28% | 0.21% |
| Operating Margin (TTM) | 0.30% | 0.25% |
| Return on Equity (TTM) | 0.24% | 0.12% |
| Debt to Equity (MRQ) | 24.00 | 0.76 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $33.56 | $39.31 |
| Cash per Share (MRQ) | $18.52 | $17.40 |
| Operating Cash Flow (TTM) | $244.38M | $280.52M |
| Levered Free Cash Flow (TTM) | $168.62M | $185.91M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Nova vs Onto Innovation
| Metric | NVMI | ONTO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 41.14 | 21.99 |
| Forward P/E | 36.17 | 14.49 |
| PEG Ratio | 36.17 | 14.49 |
| Price to Sales (TTM) | 10.78 | 4.64 |
| Price to Book (MRQ) | 8.13 | 2.47 |
| Market Capitalization | ||
| Market Capitalization | $8.02B | $4.76B |
| Enterprise Value | $7.68B | $3.91B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 10.32 | 3.82 |
| Enterprise to EBITDA | 32.97 | 14.55 |
| Risk & Other Metrics | ||
| Beta | 1.67 | 1.44 |
| Book Value per Share (MRQ) | $33.56 | $39.31 |
Financial Statements Comparison: Nova vs Onto Innovation
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NVMI | ONTO |
|---|---|---|
| Revenue/Sales | $213.36M | $266.61M |
| Cost of Goods Sold | $91.05M | $123.37M |
| Gross Profit | $122.30M | $143.23M |
| Research & Development | $33.23M | $28.03M |
| Operating Income (EBIT) | $63.23M | $63.13M |
| EBITDA | $68.13M | $76.74M |
| Pre-Tax Income | $76.17M | $71.66M |
| Income Tax | $11.35M | $7.56M |
| Net Income (Profit) | $64.82M | $64.10M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NVMI | ONTO |
|---|---|---|
| Cash & Equivalents | $141.06M | $203.73M |
| Total Current Assets | $875.74M | $1.47B |
| Total Current Liabilities | $401.78M | $174.48M |
| Long-Term Debt | $47.66M | $8.66M |
| Total Shareholders Equity | $982.12M | $1.92B |
| Retained Earnings | N/A | $671.12M |
| Property, Plant & Equipment | $139.85M | $13.49M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NVMI | ONTO |
|---|---|---|
| Operating Cash Flow | $73.99M | $81.15M |
| Capital Expenditures | $-8.86M | $-8.23M |
| Free Cash Flow | $59.69M | $83.75M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-20.00M | $-75.02M |
Short Interest & Institutional Ownership Analysis
| Metric | NVMI | ONTO |
|---|---|---|
| Shares Short | 1.64M | 2.06M |
| Short Ratio | 6.28 | 1.77 |
| Short % of Float | 0.06% | 0.06% |
| Average Daily Volume (10 Day) | 279,150 | 1,217,430 |
| Average Daily Volume (90 Day) | 286,683 | 1,133,060 |
| Shares Outstanding | 29.28M | 49.24M |
| Float Shares | 29.22M | 48.52M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 0.77% | 0.98% |
Dividend Analysis & Yield Comparison: Nova vs Onto Innovation
| Metric | NVMI | ONTO |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |